*By Jacqueline Corba* MedMen, an American cannabis company based in Los Angeles, began trading on the Canadian Stock Exchange on Tuesday, earning a valuation of $1.1 billion. "Today is day one," co-founder and CEO Adam Bierman said in an interview with Cheddar. "There is nothing quick in regards to anything having to do with our industry. This is a long play." MedMen has 18 licensed facilities in California, Nevada, and New York. The company recently opened a medical marijuana dispensary on 5th Avenue in Manhattan with a high-tech and minimalist design that has prompted comparisons with an Apple store. But unlike tech companies, even legal cannabis companies in the United States don't have access to institutional capital. That's why MedMen had to go to Canada. "They are the second American cannabis company to do it, they are not going to be the last," said Greg Zeman, associate editor at Cannabis Now. "Everybody is looking for capital and affordable capital is not in heavy supply down here, and it is pretty abundant when you get up to Canada. It's like any rushーeveryone is trying to get in it now." With an infusion of capital from the company's public listing ー six percent of the company was opened up for public sharesー MedMen's Bierman said the company will expand its retail operations and open new growing facilities. And maybe sometime in the future, the company could be listed in New York and Bierman can ring the bell at the New York Stock Exchange. "Prohibition will end here in the U.S.," Bierman said. "Bureaucracy is there for a reason, I don't think we want to change laws overnight here in this country. I think its good it goes through a process and takes time." The next cannabis company to go through a similar process may be Orchid Essentials. That company's co-founder, Corey Mangold, told Cheddar's CannaBiz he plans to take his company public on the Canadian stock market in the fall. Mangold laments the fact that he can't list his company in the United States, but said he was confident that change is coming to medical and recreational use of marijuana. "It's time that we grab a hold and make a change that is long overdue," Mangold said.

Share:
More In Business
Watchdog Slams IRS Identity Theft Case Delays as “Unconscionable”
An independent watchdog within the IRS reports that while taxpayer services have vastly improved, the agency is still too slow to resolve identity theft cases. And National Taxpayer Advocate Erin Collins says those delays are “unconscionable.” Erin M. Collins said in the report released Wednesday that overall the 2024 filing season went smoothly, though IRS delays in resolving identity theft victim assistance cases are worsening. It took nearly 19 months to resolve self-reported identity theft cases as of January, and Wednesday's report states that now it takes 22 months to resolve these cases.
A.I. Investments Carry Amazon Over $2 Trillion Valuation Threshold
Amazon.com Inc. surpassed $2 trillion in market value for the first time in afternoon trading on Wednesday. The push higher for Amazon’s stock market valuation comes a little more than a week after Nvidia hit $3 trillion and briefly became the most valuable company on Wall Street. Nvidia’s chips are used to power many AI application and its valuation has soared as a result. Amazon has also been making big investments in AI as global interest has grown in the technology. Most of the company’s focus has been on business-focused products.
Load More